Suppr超能文献

加强拉丁美洲的疫苗接种政策:循证方法。

Strengthening vaccination policies in Latin America: an evidence-based approach.

机构信息

Carlos Slim Health Institute, D.F., Mexico.

出版信息

Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.

Abstract

Despite many successes in the region, Latin American vaccination policies have significant shortcomings, and further work is needed to maintain progress and prepare for the introduction of newly available vaccines. In order to address the challenges facing Latin America, the Commission for the Future of Vaccines in Latin America (COFVAL) has made recommendations for strengthening evidence-based policy-making and reducing regional inequalities in immunisation. We have conducted a comprehensive literature review to assess the feasibility of these recommendations. Standardisation of performance indicators for disease burden, vaccine coverage, epidemiological surveillance and national health resourcing can ensure comparability of the data used to assess vaccination programmes, allowing deeper analysis of how best to provide services. Regional vaccination reference schemes, as used in Europe, can be used to develop best practice models for vaccine introduction and scheduling. Successful models exist for the continuous training of vaccination providers and decision-makers, with a new Latin American diploma aiming to contribute to the successful implementation of vaccination programmes. Permanent, independent vaccine advisory committees, based on the US Advisory Committee on Immunization Practices (ACIP), could facilitate the uptake of new vaccines and support evidence-based decision-making in the administration of national immunisation programmes. Innovative financing mechanisms for the purchase of new vaccines, such as advance market commitments and cost front-loading, have shown potential for improving vaccine coverage. A common regulatory framework for vaccine approval is needed to accelerate delivery and pool human, technological and scientific resources in the region. Finally, public-private partnerships between industry, government, academia and non-profit sectors could provide new investment to stimulate vaccine development in the region, reducing prices in the long term. These reforms are now crucial, particularly as vaccines for previously neglected, developing-world diseases become available. In summary, a regionally-coordinated health policy will reduce vaccination inequality in Latin America.

摘要

尽管拉丁美洲在这方面取得了许多成功,但疫苗政策仍存在重大缺陷,需要进一步努力来保持进展并为新疫苗的推出做好准备。为了解决拉丁美洲面临的挑战,拉丁美洲疫苗未来委员会(COFVAL)提出了加强循证决策和减少免疫区域不平等的建议。我们进行了全面的文献综述,以评估这些建议的可行性。疾病负担、疫苗覆盖率、流行病学监测和国家卫生资源的绩效指标的标准化可以确保用于评估疫苗接种计划的数据的可比性,从而可以更深入地分析如何最好地提供服务。可以借鉴欧洲使用的区域疫苗参考计划,为疫苗引入和计划制定制定最佳实践模型。为持续培训疫苗提供者和决策者制定了成功的模式,新的拉丁美洲文凭旨在为成功实施疫苗接种计划做出贡献。以美国免疫实践咨询委员会(ACIP)为基础的常设、独立疫苗咨询委员会,可以促进新疫苗的采用,并支持国家免疫规划管理中的循证决策。为购买新疫苗而采用的创新融资机制,如预付款市场承诺和成本前置,已显示出提高疫苗覆盖率的潜力。需要建立一个共同的疫苗监管框架,以加速交付并汇集该地区的人力、技术和科学资源。最后,行业、政府、学术界和非营利部门之间的公私合作伙伴关系可以为该地区的疫苗开发提供新的投资,从而从长期来看降低价格。这些改革现在至关重要,特别是因为以前被忽视的发展中国家疾病的疫苗即将面世。总之,协调一致的区域卫生政策将减少拉丁美洲的疫苗接种不平等。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验